As of today (2024-04-18), Steris's share price is $200.81.
Steris's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.95. Hence, Steris's Price-to-Free-Cash-Flow Ratio for today is 33.73.
The historical rank and industry rank for Steris's Price-to-Free-Cash-Flow or its related term are showing as below:
STE'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.89 Med: 33.69 Max: 63.01
Current: 33.73
During the past 13 years, Steris's highest Price-to-Free-Cash-Flow Ratio was 63.01. The lowest was 16.89. And the median was 33.69.
STE's Price-to-Free-Cash-Flow is ranked worse than 55.36% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 31.405
vs STE: 33.73
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Steris was 71.30% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -3.50% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 2.50% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 8.90% per year.
During the past 13 years, Steris's highest 3-Year average Free Cash Flow per Share Growth Rate was 62.40% per year. The lowest was -20.70% per year. And the median was 7.50% per year.
Steris Price-to-Free-Cash-Flow Historical Data
The historical data trend for Steris's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Steris Annual Data
Trend
Mar14
Mar15
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Mar23
Price-to-Free-Cash-Flow
31.28
31.88
36.33
59.84
48.55
Steris Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Price-to-Free-Cash-Flow
53.13
48.55
45.59
40.97
36.92
Competitive Comparison
For the Medical Devices subindustry, Steris's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris Price-to-Free-Cash-Flow Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Steris's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Steris's Price-to-Free-Cash-Flow falls into.
Steris Price-to-Free-Cash-Flow Calculation
Steris's Price-to-Free-Cash-Flow ratio for today is calculated as
Steris's Share Price of today is $200.81.
Steris's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.95.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Steris Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Steris's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STE has been successfully added to your 